Up more than 70% since March, we believe Texas Instruments stock (NASDAQ: TXN) could see significant downside. TXN stock is up more than 25% so far this year. It traded at $133 in February 2020 – just before the outbreak of coronavirus – and is currently 20% above that level, as well. Further, due to poor Q3 2019 results, and unlikely demand growth in the near to medium term, the stock has the potential to drop almost 20% to its pre-Covid level of around $130. Our conclusion is based on our comparative analysis of Texas Instruments stock performance during the current crisis with that during the 2008 recession in our interactive dashboard.
2020 Coronavirus Crisis
Timeline of 2020 Crisis So Far:
- 12/12/2019: Coronavirus cases first reported in China
- 1/31/2020: WHO declares a global health emergency.
- 2/19/2020: Signs of effective containment in China and hopes of monetary easing by major central banks helps S&P 500 reach a record high
- 3/23/2020: S&P 500 drops 34% from the peak level seen on Feb 19, as COVID-19 cases accelerate outside China. Doesn’t help that oil prices crash in mid-March amid Saudi-led price war
- Since 3/24/2020: S&P 500 recovers 67% from the lows seen on Mar 23, as the Fed’s multi-billion dollar stimulus package suppresses near-term survival anxiety and infuses liquidity into the system.
- How Has Texas Instruments Stock Managed To Outperform The Markets Since ’18?
- Here’s Why Texas Instruments’ 1.8x Move Since 2018 Does Not Come As A Surprise
- Here’s What Makes Microchip Technology Stock A Strong Semiconductor Play
- After A Dismal Performance Last Month, Texas Instruments Stock Looks Set To Bounce
- Thinking Of Buying Intel Stock? Buy Texas Instruments Instead
- Despite Recent Earnings Growth, Texas Instruments Stock Could Drop To $165
In contrast, here is how TXN stock and the broader market fared during the 2007-08 crisis.
Timeline of 2007-08 Crisis
- 10/1/2007: Approximate pre-crisis peak in S&P 500 index
- 9/1/2008 – 10/1/2008: Accelerated market decline corresponding to Lehman bankruptcy filing (9/15/08)
- 3/1/2009: Approximate bottoming out of S&P 500 index
- 12/31/2009: Initial recovery to levels before accelerated decline (around 9/1/2008)
TXN and S&P 500 Performance Over 2007-08 Financial Crisis
We see TXN stock declined from levels of around $36 in October 2007 (pre-crisis peak) to levels of around $14 in March 2009 (as the markets bottomed out), implying TXN stock lost 60% from its approximate pre-crisis peak. It recovered post the 2008 crisis, to levels of $26 in early 2010, rising by more than 80% between March 2009 and January 2010. The S&P 500 Index saw a decline of 51%, falling from levels of 1,540 in September 2007 to 757 in March 2009. It then rallied to levels of 1,124, rising by about 48% between March 2009 and January 2010.
TXN Fundamentals Over Recent Years
TXN revenues increased from $13 billion in 2015 to $14.4 billion in 2019. Despite, an increase of just around 10% in revenues, EPS rose 90% from $2.86 to $5.33 over this period, as a result of a drop across all operating expense heads.
Does TXN Have Enough Cash Cushion To Meet Its Obligations Through The Coronavirus Crisis?
TXN’s total debt jumped from $3.6 billion in 2016 to $5.8 billion in 2019, and its total cash also rose from around $3.5 billion to $5.4 billion over the same period. Further, the company generated around $6.6 billion cash from operations in fiscal 2019. A steady cash cushion combined with a strong operating cash flow, provides the company the means to deal with the current crisis.
Phases of Covid-19 Crisis:
- Early- to mid-March 2020: Fear of the coronavirus outbreak spreading rapidly translates into reality, with the number of cases accelerating globally
- Late-March 2020 onward: Social distancing measures + lockdowns
- April 2020: Fed stimulus suppresses near-term survival anxiety
- May-June 2020: Recovery of demand, with gradual lifting of lockdowns – no panic anymore despite a steady increase in the number of cases
- July-November 2020: Weak Q2 and Q3 results, but continued improvement in demand and progress with vaccine development buoy market sentiment
With the recent surge in the number of new Covid-19 cases in the U.S., and the impact on industrial and manufacturing activities, we expect analog semiconductor sales to struggle in the near term. If the company is not able to simultaneously control expenses, the drop in sales could further weigh on EPS. We believe that TXN stock has significant potential downside in the near term, and even as the lockdowns are gradually lifted, revenues will stay weak in the near to medium term. This could see TXN stock potentially drop 20% from its current level.
What if you’re looking for a more balanced portfolio instead? Here’s a high quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.